Beckman Coulter, Inc.
250 S Kraemer Blvd
Brea
CA
92821
United States
Tel: (714) 993-5321
Website: http://www.beckmancoulter.com/
325 articles about Beckman Coulter, Inc.
-
Beckman Coulter and Fujirebio Expand Partnership to Develop Patient-friendly, Blood-based Neurodegenerative Disease Diagnostics
3/12/2024
Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro Diagnostic manufacturing, announced an expansion of their partnership focused on development, manufacturing and clinical adoption of neurodegenerative disease assays.
-
Beckman Coulter Diagnostics Appoints Kevin O'Reilly as New President
2/6/2024
Beckman Coulter Diagnostics announced Kevin O'Reilly's appointment as its new president succeeding Julie Sawyer Montgomery, who is now vice president and group executive, Danaher Diagnostics.
-
Beckman Coulter's DxI 9000 Immunoassay Analyzer with Increased Assay Development Sensitivity Makes First North American Appearance at 2023 AACC
7/25/2023
Beckman Coulter, a clinical diagnostics leader, today revealed for the first time in North America the DxI 9000 Access Immunoassay Analyzer, addressing clinical laboratory demands for speed, reliability, reproducibility, quality, and menu expansion
-
Beckman Coulter Connects Scopio Labs Digital Cell Morphology with Hematology Workcell Extending Automated Workflow
7/19/2023
Beckman Coulter, a global leader in clinical diagnostics, today announced it will debut its hematology analyzer and slidemaker stainer connected to Scopio Labs' digital morphology platform for end-to-end digitization with artificial intelligence-assisted peripheral blood smear analysis at the 2023 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting and Clinical Lab Expo.
-
Beckman Coulter and Fujirebio Partner to Bolster Access to Patient-friendly, Blood-based Alzheimer’s Disease Test Therapeutics
7/17/2023
Beckman Coulter Diagnostics and In Vitro Diagnostic (IVD) manufacturing, today announced a new partnership combining their respective immunoassay strengths to support therapeutic development, clinical trials, reimbursement, and routine clinical adoption in the field of neurodegenerative diseases.
-
Beckman Coulter Unveils Next Generation Immunoassay Analyzer Enabling Elite Laboratory Performance with No Daily Maintenance
5/15/2023
Beckman Coulter, a clinical diagnostics leader, unveiled the DxI 9000 Access Immunoassay Analyzer, the most productive immunoassay analyzer per footprint.
-
Beckman Coulter and Scopio Labs Partner to Accelerate Adoption of Hematology Digital Cell Morphology Platform
7/20/2022
Beckman Coulter, a global leader in clinical diagnostics, and Scopio Labs, a medtech company that develops AI-powered workflow solutions, announced today a worldwide partnership to accelerate adoption of Scopio's next generation peripheral blood smear platforms.
-
Beckman Coulter's new urinalysis solution improves laboratory workflow by significantly reducing manual reviews to 4%(1) and cutting sample processing time by up to 78%(2)
9/28/2021
Beckman Coulter announced the launch of its DxU Iris Workcell at the AACC Annual Scientific Meeting & Clinical Lab Expo.
-
Beckman Coulter Launches First Fully Quantitative and Automated COVID-19 IgG Test to Assess Antibody Immune Response Levels
5/19/2021
Beckman Coulter, a global clinical diagnostics leader, announced the launch of Access SARS-CoV-2 IgG, a fully-quantitative lab-based Immunoglobulin G serology test that measures the quantity of antibodies against the virus that causes COVID-19.
-
Beckman Coulter is First Diagnostics Company to Offer Workflow Automation Specifically for Mid-volume Laboratories
5/4/2021
Beckman Coulter, a clinical diagnostics leader, today announced the global launch of the DxA 5000 Fit, a workflow-automation solution designed to fit into medium-sized labs that run fewer than 5,000 tests a day.
-
Beckman Coulter's SARS-CoV-2 IgG II antibody test receives Emergency Use Authorization from the FDA
3/23/2021
- Lenco Diagnostic Laboratories among first to offer Beckman Coulter's semi-quantitative antibody test; Lab expects clinicians will use assay to monitor patients' COVID-19 recovery and assess immune response over time[1]
-
Beckman Coulter brings the productivity and efficiency benefits of large volume hematology analyzers to small- and medium-sized labs
1/25/2021
With less than a drop of blood, one of the lowest sample volumes on the market, the analyzer delivers high-quality results in 60 seconds or less
-
Beckman Coulter Launches the First High-Quality, High-Throughput COVID-19 Antigen Test Ideal for Mass Testing in the U.S.
12/18/2020
The Access SARS-CoV-2 Antigen assay is offered to healthcare providers at $4, making reliable and frequent mass testing affordable
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 20, 2020.
-
The grant was awarded by the U.S. Dept. of Health and Human Service’s Biomedical Advanced Research and Development Authority (BARDA).
-
Beckman Coulter Completes First In A Series Of Antibody Neutralization Studies
10/6/2020
Access SARS-CoV-2 IgG assay shows excellent agreement with surrogate virus neutralization test which identifies antibodies that block the interaction between virus and host cell receptor
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 2, 2020.
-
Study shows patients with abnormal values of Beckman Coulter's novel MDW biomarker are four- to six- times more likely to be diagnosed with (or develop) sepsis
8/5/2020
Beckman Coulter announced new analysis from the pivotal study of its novel monocyte distribution width hematologic biomarker for sepsis detection.
-
Beckman Coulter Wins SelectScience Awards for Best New Clinical Instrumentation and Customer Service of the Year
7/21/2020
Beckman Coulter, a global leader in clinical diagnostics, announced today that it received the Scientists' Choice Award® for Best New Clinical Laboratory Instrumentation of 2019 for its DxA 5000 Total Laboratory Automation System, as well as the Reviewer's Choice Award for Clinical Customer Service of the Year.
-
Beckman Coulter, Lenco Diagnostic Laboratories deliver more than 20,000 highly accurate COVID-19 antibody tests each week to New York City; Congressman Max Rose and Brooklyn Borough President Eric Adams applaud boost in testing resources
7/6/2020
40,000 of Beckman Coulter's new Access SARS-CoV-2 IgG Antibody tests already received by New York City through Lenco Labs